Umlobi: Charles Brown
Usuku Lokudalwa: 7 Ufebhuwari 2021
Ukuvuselela Usuku: 21 Unovemba 2024
Anonim
Atopic Dermatitis: Pathogenesis
Ividiyo: Atopic Dermatitis: Pathogenesis

-Delile

I-Tarfic ingamafutha ane-tacrolimus monohydrate ekubunjweni kwayo, okuyisithako esingaguqula ukuphendula komzimba kwesikhumba, kuqede ukuvuvukala nezinye izimpawu ezinjengokubomvu, isifuba kanye nokulunywa, ngokwesibonelo.

Lo mafutha angathengwa emakhemisi ajwayelekile, ngemuva kokwethula incwadi kadokotela, ngokugxila okungu-0.03 noma u-0.1% kumashubhu ka-10 noma 30 amagremu, ngentengo engahluka phakathi kwama-reais ama-50 no-150.

Yenzelwe ini

Amafutha e-Tarfic akhonjisiwe ekwelapheni i-atopic dermatitis kubantu abangaphenduli kahle noma abangakubekezeleli ukwelashwa okuvamile kanye nokukhululeka kwezimpawu nokulawulwa kokuqubuka kwe-atopic dermatitis. Thola ukuthi kuyini nokuthi ungabona kanjani i-atopic dermatitis.

Ngaphezu kwalokho, ibuye isetshenziselwe ukugcina ukwelashwa kwe-atopic dermatitis, ukuvimbela ukuqubuka kwezimpawu nokwandisa ukungaqhamuki kwezifo ezigulini ezinezifo eziningi eziba zimbi kakhulu.


Ngokuvamile, iTarfic 0.03% ikhonjiswa ukuthi isetshenziswe ezinganeni ezineminyaka ephakathi kwengu-2 kuya kwengu-15 ubudala kanye nabantu abadala kanti iTarfic 0.1% ikhonjisiwe ukuthi isetshenziswe kubantu abangaphezu kweminyaka engu-16 ubudala.

Isetshenziswa kanjani

Ukuze usebenzise iTarfic, ungqimba oluncane kufanele lusetshenziswe ezindaweni ezithintekile zesikhumba, kugwenywe izindawo ezinjengekhala, umlomo noma amehlo nokugwema ukumboza isikhumba lapho kufakwa khona amafutha, ngamabhandeshi noma olunye uhlobo lokunamathisela.

Ngokuvamile, isilinganiso sikaTarfic ukusebenzisa umuthi wamafutha izikhathi ezi-2 kuya kwezintathu ngosuku, amasonto amathathu bese kanye ngosuku, kuze kube yilapho umcabango unyamalala ngokuphelele.

Udokotela futhi angancoma ukusetshenziswa kweTarfic, cishe amahlandla ama-2 ngeviki, uma ukuqubuka sekunyamalele, ezifundeni ezivame ukuthinteka futhi uma izimpawu ziphinda zivela, udokotela angabuyela ukuzokhombisa isilinganiso sokuqala.

Ngemuva kokugcoba amafutha, kunconywa ukuthi ugeze izandla zakho, ngaphandle uma ukwelashwa kwenziwa kule ndawo.

Imiphumela emibi engaba khona

Eminye yemiphumela emibi kakhulu engenzeka ngesikhathi sokwelashwa ngeTarfic ukunwaya nokushisa endaweni yokufaka isicelo, evame ukunyamalala ngemuva kwesonto lokusebenzisa lo muthi.


Ngaphezu kwalokho, yize kungenzeki kaningi, ububomvu, ubuhlungu, ukucasuka, ukwanda kwesikhumba ekuzameni kokushisa, ukuvuvukala kwesikhumba, ukutheleleka kwesikhumba, i-folliculitis, i-herpes simplex, isilonda esifana nenkukhu, i-impetigo, i-hyperesthesia, i-dysesthesia kanye nokungabekezelelani kotshwala.

Ngubani ongafanele asebenzise

I-Tarfic iyaphikiswa kwabesifazane abakhulelwe, abesifazane abancancisayo nezingane ezineminyaka engaphansi kwemibili ubudala, kanye nabantu abanenkinga yokungezwani komzimba nama-antibiotic e-macrolide, njenge-azithromycin noma i-clarithromycin, noma izingxenye zefomula.

Kudume Ku-Portal

I-Hypoparathyroidism

I-Hypoparathyroidism

I-Hypoparathyroidi m yi ifo lapho izindlala ze-parathyroid entanyeni zingakhiqizi i-hormone eyanele ye-parathyroid (PTH).Kunezinhlayiya ezine ezincane ze-parathyroid entanyeni, e eduze noma enamathi e...
I-Casirivimab ne-Imdevimab Injection

I-Casirivimab ne-Imdevimab Injection

Inhlangani ela ye-ca irivimab ne-imdevimab okwamanje ifundelwa ukwela hwa kwe ifo e-coronaviru 2019 (COVID-19) e ibangelwa igciwane le- AR -CoV-2.Imininingwane ye ivivinyo omtholampilo enomkhawulo kup...